| General Information of Drug Metabolite (DM) (ID: DM019770) |
| DM Name |
BMS-690514 M2
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
DME0009
|
| Unclear - Unclear |
BMS-690514
|
[1] |
|
Cytochrome P450 3A4 (CYP3A4)
|
DME0001
|
| Unclear - Unclear |
BMS-690514
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| BMS-690514 |
DR3195
|
Phase 2 |
Chronic pain |
|
|
| References |
| 1 |
Metabolism and disposition of [14C]BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor, after oral administration to humans
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
